Pharmaceutical Technology

MAY 24, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Recombinant viral vector-based medicinal preparations. However, not all innovations are equal and nor do they follow a constant upward trend.

Medicine 130

Medicine Vaccination Vaccine Gene 130

Pharmaceutical Technology

APRIL 10, 2023

The Australian Government’s Department of Health and Aged Care has announced the availability of new medicines for graft versus host disease (GVHD), chronic rhinosinusitis, and oesophageal cancer. Time is of the essence for patients living with GVHD and their caregivers, who have had no other, or limited, treatment options until now.

Medicine 130

Medicine Production 130

Pharmaceutical Technology

MARCH 24, 2023

Moderna has entered a strategic partnership with Generation Bio for the development of non-viral genetic medicines. Moderna’s biological and technical expertise will be combined with core technologies of the non-viral genetic medicine platform from Generation Bio.

Genetics 130

Genetics Medicine Development In-Vivo 130

Pharmaceutical Technology

MAY 17, 2023

Under the deal, Prevail obtains exclusive rights to use Scribe’s CRISPR X-Editing (XE) technologies to develop the medicines. The deal will see the integration of Scribe’s new CRISPR by Design approach and Prevail’s expertise in developing genetic medicines for neurological disorders for specific genetic targets.

Genetics 130

Genetics Medicine Gene Therapy In-Vivo 130

Pharmaceutical Technology

MAY 15, 2023

Chinese biotech company LaNova Medicines and AstraZeneca have entered an exclusive licence deal for La Nova’s LM-305. LaNova Medicines founder, chair and CEO Dr Crystal Qin stated: “LaNova Medicines has a strong focus on discovering and developing innovative medicines in the ADC and immuno-oncology fields.

Medicine 130

Medicine Antibody Drugs Protein 130

Pharmaceutical Technology

JANUARY 3, 2023

Blacksmith Medicines has signed a definitive merger agreement with Forge Therapeutics to create a combined entity that will discover and develop medicines targeting a large class of proteins called metalloenzymes. The merged entity will focus on developing medicines with an initial focus on oncology and infection.

Medicine 130

Medicine Genome Genomics DNA 130

Pharmaceutical Technology

DECEMBER 6, 2022

Ongoing drug shortages are not a new occurrence, but a rise in shortages following the pandemic and other global events is leaving many patients unable to access the medicines they need. In addition to medicine distribution, the company can also provide health supplies, PPE, diagnostics, and other medical materials. Free Whitepaper.

Medicine 221

Medicine Drugs Manufacturing Pharma Production 221

Pharmaceutical Technology

MAY 8, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Zinc-based medicinal compositions. However, not all innovations are equal and nor do they follow a constant upward trend.

Medicine 130

Medicine Antibody DNA Protein 130

Pharmaceutical Technology

APRIL 12, 2023

Cognizant and Boehringer Ingelheim are collaborating on an integrated cloud platform to enhance the speed and quality of medicinal therapy development. Cognizant will leverage the Veeva Development Cloud platform to help Boehringer Ingelheim to merge medicinal development processes and data into a connected technology ecosystem.

Medicine 130

Medicine Life Science Clinical Development Development 130

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 16, 2023

The MoA is for collaboration and cooperation in health research in the field of integrated medicine. In a move to strengthen the country’s health infrastructure and to integrate and mainstream Ayush sector, the Ministry of Ayush and the Indian Council of Medical Research (ICMR) have signed a Memorandum of Agreement (MoA).The

Medicine 156

Medicine Research Clinical Trials Clinical Trials 156

Pharmaceutical Technology

FEBRUARY 3, 2023

The field of genomic medicine has reached a true turning point. In June 2022, the European Medicines Agency approved an adeno-associated viral (AAV) vector-based therapy for adults with Hemophilia A, making the treatment available to an estimated 3,200 eligible patients. [1] CEVEC became part of Cytiva in October 2022.

Genome 244

Genome Genomics Gene Therapy Medicine 244

Pharmaceutical Technology

APRIL 27, 2023

Orbital will use the new funding to increase the application of RNA-based medicines for use in the fields of new vaccines, immunomodulation and protein replacement. New investors included the Redmile Group, the Abu Dhabi Growth Fund (ADG), Exor, Invus, Moore Strategic Ventures, the iGlobe Platinum Fund Group and Casdin Capital.

RNA 130

RNA Medicine Gene Therapy Gene 130

Pharmaceutical Technology

NOVEMBER 1, 2022

Intrinsic Medicine has signed a definitive business combination agreement with special purpose acquisition (SPAC) firm Phoenix Biotech Acquisition to create a public company. To be named Intrinsic Medicine following closing, the combined company will be led by current Intrinsic CEO Alexander Martinez and president and COO Jason Ferrone.

Medicine 147

Medicine Clinical Trials Clinical Trials Drugs 147

Pharmaceutical Technology

MAY 25, 2023

To help healthcare providers encourage higher levels of medicines adherence, RPM and companion apps can provide encouragement by addressing the following areas: Doctor-patient relationships. These send reminders to the patient when it is time to take the medication, and sometimes include a checklist within the app.

Medicine 130

Medicine Doctors Doctor Regulation 130

Pharmaceutical Technology

MAY 29, 2023

The global pharmaceutical industry experienced a 24% drop in company filings mentions of regenerative medicine in Q1 2023 compared with the previous quarter, with the highest share accounted for by Sarepta Therapeutics with 20% year-on-year decrease, according to GlobalData’s analysis of over 578 pharmaceutical company filings.

Medicine 100

Medicine Research 100

Rethinking Clinical Trials

MAY 3, 2023

Joshua Denny, All of Us Research Program (Photo: Vanderbilt University Medical Center) In this Friday’s PCT Grand Rounds, Joshua Denny of the All of Us Research Program at NIH, will present “ All of Us Research Program: Improving Health Through Diverse Technology, Huge Cohorts, and Precision Medicine.”

Medicine 130

Medicine Clinical Trials Clinical Trials Trials 130

Pharmaceutical Technology

JANUARY 4, 2023

Belharra Therapeutics and Roche Group member Genentech have announced a partnership for the discovery and development of new small molecule medicines across several therapeutic areas. The post Belharra and Genentech partner for small molecule medicines development appeared first on Pharmaceutical Technology.

Medicine 130

Medicine Development Drugs Sales 130

BioPharma Reporter

MAY 18, 2023

Sania Therapeutics, a new biotech company focused on developing genetic medicines for neural circuit dysfunction, has launched by unveiling its suite of proprietary patented platforms at the American Society of Gene & Cell Therapy (ASGCT) conference.

Medicine 97

Medicine Gene Genetics Development 97

Pharmaceutical Technology

JULY 1, 2022

Blueprint Medicines has entered strategic financing partnerships for up to $1.25bn with life sciences-focused investors Sixth Street and Royalty Pharma. Under the deal, Blueprint Medicines will receive an upfront cash payment of $175m as well as up to $165m in potential milestone payments contingent on sales in the future.

Medicine 147

Medicine FDA Approval Life Science Drugs 147

Pharmaceutical Technology

AUGUST 11, 2022

Gemini Therapeutics has signed a definitive agreement to merge with Disc Medicine in an all-stock deal to create a clinical-stage biopharmaceutical company. The merged company is expected to be named Disc Medicine, which will have corporate headquarters in Watertown, Massachusetts, US. To back the merger, Disc raised funds worth $53.5m

Medicine 147

Medicine Clinical Trials Clinical Trials Antibody 147

Bio Pharma Dive

MAY 25, 2022

The new initiative commits Pfizer to supplying current and future branded medicines at lower cost to 45 countries. The pharma has been criticized for not doing enough to make its COVID-19 vaccine and pill available globally.

Medicine 244

Medicine Vaccination Vaccine Sales 244

Pharmaceutical Technology

DECEMBER 15, 2022

Medicines experience a 16% price drop on average post-ATU/early access. GlobalData identified 17 medicines, including eight orphan medicines, that were first available under an early access programme or previous ATU and that are now priced under standard pricing and reimbursement procedures.

Medicine 147

Medicine Drugs Marketing Branding 147

Medical Xpress

APRIL 29, 2023

Paediatricians from European countries have raised the alarm over a shortage of medicines for children including antibiotics and asthma treatment, warning it was endangering health.

Medicine 105

Medicine 105

World of DTC Marketing

DECEMBER 4, 2020

Digital medicine has been thrust into the spotlight because of the pandemic and the media hype is in overdrive. A study of some 16m American ones just reported in jama Internal Medicine , a journal, found that their use of telemedicine surged 30-fold between January and June. ” Digital medicine also needs better clarification.

Medicine 201

Medicine Doctors Doctor Pharmacy 201

Pharmaceutical Technology

NOVEMBER 21, 2022

RVAC Medicines has signed a master research partnership agreement with the Agency for Science, Technology and Research (A*STAR) for analysing and developing solutions to build messenger ribonucleic acid (mRNA) manufacturing and analytics expertise in Singapore. Topic sponsors are not involved in the creation of editorial content.

Medicine 130

Medicine Manufacturing Gene Therapy Vaccination 130

Pharmaceutical Technology

JULY 7, 2022

But scientists have struggled to find effective treatments for many of these diseases since the dawn of modern medicine. It is certainly a pivotal moment for the cell and gene industry, with the next decade of R&D and clinical trials expected to transform the future of medicine.

Gene Therapy 245

Gene Therapy Gene Medicine Clinical Trials 245

Bio Pharma Dive

APRIL 25, 2023

Biogen’s drug failed the key study meant to show it can slow the nerve-destroying disease, but the drug’s effect on a protein of interest led the FDA to conditionally clear it for market.

FDA Approval 345

FDA Approval Medicine Protein Drugs 345

Rethinking Clinical Trials

APRIL 5, 2023

In this Friday’s PCT Grand Rounds, Srinath Adusumalli of the University of Pennsylvania will present “A Nudge Towards Cardiovascular Health: Applications of Behavioral and Implementation Science in Cardiovascular Medicine.” ” The Grand Rounds session will be held on Friday, April 7, 2023, at 1:00 pm eastern.

Medicine 130

Medicine Clinical Trials Clinical Trials Trials 130

pharmaphorum

JANUARY 20, 2023

Leela Barham argues that the latest operational guidance for the NHS in England continues to illustrate a disconnect between the messages in big-ticket policy documents from the central government and the messages from the NHS in England on medicines. For that, the government has set out the Life Sciences Vision , published back in July 2021.

Medicine 105

Medicine Life Science Branding Drugs 105

Pharmaceutical Technology

JULY 5, 2022

Through the Impact brand, which comprises insulin, glibenclamide and oxaliplatin among others, the company will supply its 30 medicines in 40 lower-income countries in the world. The post Sanofi unveils global health brand for medicines supply appeared first on Pharmaceutical Technology.

Medicine 147

Medicine Branding Insulin Antibody 147

Pharmaceutical Technology

APRIL 13, 2023

Clinical-stage biopharmaceutical firm Alentis Therapeutics has raised $105m in a Series C financing round for advancing transformational medicines targeting the CLAUDIN-1 protein.

Medicine 130

Medicine Antibody Development Protein 130

Pharmaceutical Technology

APRIL 4, 2023

Abacus Medicine Pharma Services (AMPS) and Laboratoires CTRS, marketing authorization holder of Orphacol®, are proud to announce a strategic partnership that ensures continuous stock of Orphacol® in Spain. Our ambition is to provide better access to medicines and better healthcare to patients around the world.

Medicine 130

Medicine Genetic Disease Genetics Marketing 130

Pharma Mirror

AUGUST 30, 2022

The post Testing Facility Called “Game Changer” in Regenerative Medicine appeared first on Pharma Mirror Magazine. Cytocentric cell manufacturing keeps the critical cell process parameters of temperature, CO2, and O2 at optimum physiologic levels over the entire production process, not just during incubation steps.

Medicine 130

Medicine In-Vitro Manufacturing Production 130

Pharmaceutical Technology

JULY 22, 2022

Sangamo Therapeutics has received orphan medicinal product designation (OMPD) from the European Commission (EC) for its Investigational autologous Chimeric Antigen Receptor Regulatory T Cell (CAR-Treg) cell therapy, TX200, for solid organ transplantation.

Medicine 130

Medicine Production Genome Genomics 130

pharmaphorum

MAY 31, 2023

PM Society’s ‘Securing Market Access to Medicines for England, Ireland, Scotland & Wales’ – part one Mike.Hammerton Wed, 05/31/2023 - 12:45 Bookmark this

Medicine 97

Medicine Marketing 97

Medical Xpress

MAY 9, 2023

Sports and exercise medicine must up its game to break the cycle of gender bias in the specialty, urge an international group of doctors in an editorial in the open access journal BMJ Open Sport & Exercise Medicine.

Medicine 91

Medicine Doctors Doctor 91

Bio Pharma Dive

FEBRUARY 11, 2021

Ensoma Therapeutics debuts with a lucrative alliance with the Japanese pharma and an unusual way to deliver genetic medicines into the body.

Genetics 328

Genetics Medicine 328